The BAMF Health Podcast

In this episode, Christine VanTimmeren and Dr. Brandon Mancini are joined by Afton DeVos, Consulting Director of the Foundation for Medical Advancement and Breakthroughs (FMAB).This conversation explores the origin and mission of FMAB—created in response to grateful patients who wanted to help others access life-saving care. Together, they discuss how the foundation is working to remove financial barriers, accelerate research, and expand education so more patients can benefit from cutting-edge therapies.Afton shares her deeply personal connection to this work as a cancer survivor and caregiver, and how her family’s experience—including the loss of her father while awaiting a clinical trial—fuels the urgency behind expanding access and speeding innovation.We also break down the foundation’s three core pillars:Access – Helping patients overcome financial barriers to treatmentResearch – Supporting clinical trials and accelerating innovationEducation – Raising awareness about available therapies and opportunitiesThis episode is a powerful look at how philanthropy, innovation, and patient-centered care come together to change lives—and save them.Chapters00:00 Introduction to The Foundation for Medical Advancement and Breakthroughs (FMAB)00:52 Meet Afton DeVos & Her Background03:46 How the Foundation Started 05:24 What the Foundation Does 05:30 Barriers to Care08:44 Foundation Pillars: Access, Research, Education09:36 Research: Why Faster Innovation Matters10:07 Investigator-Initiated Trials Explained11:45 Why Speed Matters in Clinical Research12:01 Afton’s Personal Story & Family Cancer Journey15:17 Funding the Foundation & Early Growth18:22 Impact of Patient & Family Donations20:07 Afton’s Shares More of Her Personal and Family Story24:41 Pancreatic Cancer & Clinical Trial Access26:11 Looking Ahead: 2026 Initiatives & Events27:56 How to Get Involved & Support the Foundation29:15 Final Thoughts on Access & ImpactConnect with the hosts on LinkedInDr. Brandon ManciniChristine VanTimmerenConnect with BAMF HealthOur WebsiteOur Podcast

Welcome to the BAMF Health Podcast, where we explore the future of theranostics, precision medicine, and personalized healthcare.In this episode, Christine VanTimmeren is joined by BAMF Health Founder & CEO Anthony Chang and Dr. Adnan Munkarah, President of Clinical Enterprise and Chief Physician Executive at Henry Ford Health, to discuss a major milestone: the groundbreaking of a new comprehensive theranostics center in downtown Detroit.This conversation dives into the strategic partnership between BAMF Health and Henry Ford Health, why Detroit was selected as BAMF’s second location, and how this new center will expand access to cutting-edge theranostics care across Michigan, the Midwest, and beyond.We explore the infrastructure and workforce challenges facing theranostics, the importance of vertical integration in radiopharmaceuticals, and how this collaboration will help train the next generation of clinicians, scientists, and healthcare professionals. Most importantly, we discuss what this means for patients—bringing earlier detection, more personalized treatment, and new hope to those who need it most.This episode highlights how partnerships like this are not just building facilities—but building the future of medicine.00:00 Introduction & Groundbreaking Announcement 00:40 Why Detroit Was Chosen for BAMF’s Expansion 02:08 Henry Ford Health’s Commitment to Detroit 03:45 Why Henry Ford Is the Right Partner 05:26 Why Henry Ford Chose BAMF 09:35 Barriers to Expanding Theranostics 10:05 Infrastructure Challenges  12:51 Access Challenges & Vertical Integration 14:44 Detroit as a Healthcare Innovation Hub 16:22 Michigan as a Leader in Precision Medicine 18:08 Transforming the Site & Community Impact 19:41 Workforce & Training the Next Generation 20:34 Building the Future Healthcare Workforce 22:17 What This Means for Patients 24:01 The Future of Early Detection & Innovation 25:28 Why Michigan Is Uniquely Positioned 26:46 The Future of Healthcare in Detroit 27:24 Final Reflections & VisionConnect with the hosts on LinkedInDr. Brandon ManciniChristine VanTimmerenConnect with BAMF HealthOur WebsiteOur Podcast

In this special World Theranostics Day episode, Christine VanTimmeren and Dr. Brandon Mancini are joined by Dr. Harshad Kulkarni, Chief Medical Advisor at BAMF Health and a global leader in theranostics, to discuss how this innovative approach is transforming cancer care and beyond.We break down what theranostics is, how it combines diagnostics and targeted therapy, and why it represents one of the most powerful shifts toward truly personalized medicine. Dr. Kulkarni shares his global experience, insights from early adoption in Europe, and how theranostics is rapidly expanding in the United States.We also explore the growing pipeline of clinical trials, the role of imaging in selecting the right patients, and how this approach is improving patient outcomes, quality of life, and survival. Finally, we look ahead to the future—where theranostics could extend beyond cancer into diseases like cardiovascular disease, Parkinson's, and more.00:00 Intro & World Theranostics Day 00:41 What Theranostics Means 02:19 Meet Dr. Harshad Kulkarni 02:54 How Dr. Kulkarni Entered Theranostics 04:20 How Europe Advanced Theranostics Earlier Than the U.S. 08:12 Why Imaging Is Essential to Theranostics 09:59 “See What You Treat, Treat What You See” 12:30 FDA-Approved Theranostics Today 15:59 Beyond Cancer: Alzheimer’s, Cardiology, and More 17:43 Why Theranostics Isn’t Available for Every Cancer Yet 21:46 Real Patient Outcomes & Quality of Life 25:34 What’s Next for Theranostics 27:11 Closing Thoughts & Learn MoreConnect with the hosts on LinkedInDr. Brandon ManciniChristine VanTimmerenConnect with BAMF HealthOur WebsiteOur Podcast

Hosts Dr. Brandon Mancini (Medical Director at BAMF Health) and Christine VanTimmeren (Marketing Manager) introduce listeners to the groundbreaking field of Theranostics, a form of precision medicine that combines advanced imaging with targeted radiopharmaceutical therapies to diagnose and treat disease.To kick off the series, they are joined by Chad Bassett, co-founder and COO of BAMF Health. Chad shares the origin story of the organization, including how a chance meeting with founder Anthony Chang led to a bold vision: building the world’s most advanced Theranostics center.In this episode, you’ll hear about:The meaning behind the name BAMF Health Why Theranostics is emerging as the next major pillar of cancer careHow BAMF Health was designed to integrate radiopharmaceutical production, imaging, and therapy in one placeThe role of clinical trials in bringing new treatments to patients fasterThe patient-centered philosophy that guides every aspect of careThe future of Theranostics in treating cancer, chronic pain, Alzheimer’s disease, and more0:00 – Welcome to the BAMF Health Podcast 0:25 – Meet the Hosts: Dr. Brandon Mancini & Christine VanTimmeren 2:19 – What is Theranostics? The Science Behind BAMF Health 4:24 – Why We Started the Podcast 6:16 – Introducing Our Guest: BAMF Health Co-Founder Chad Bassett 7:29 – The Origin Story of BAMF Health 9:20 – Why BAMF Health Was Built as a For-Profit Company 12:18 – Treating the First Patients and Early Growth 14:10 – What Makes the Patient Experience Different at BAMF 18:18 – The Role of “Time” in Patient Care 20:15 – Humanizing Healthcare 21:31 – The Future of Theranostics and Precision Medicine 22:29 – New Frontiers: Cancer, Pain, and Alzheimer’s 27:08 – Measuring Success: Giving Patients More Time 27:33 – Chad Bassett’s Personal “Why” 30:01 – Closing ThoughtsConnect with the hosts on LinkedInBrandon: https://www.linkedin.com/in/brandon-mancini-md-mba-facro-44646758/ Christine: https://www.linkedin.com/in/christinevt/Connect with BAMF HealthWebsite: https://www.bamfhealth.com/Our Podcast: https://www.bamfhealth.com/podcast/Connect with the hosts on LinkedInDr. Brandon ManciniChristine VanTimmerenConnect with BAMF HealthOur WebsiteOur Podcast

Welcome to The BAMF Health Podcast!Hosts Christine VanTimmeren, BAMF Health Marketing Manager, and Dr. Brandon Mancini, board-certified radiation oncologist and Medical Director at BAMF Health, introduce the mission behind the podcast and the innovative work happening at BAMF Health.In this episode, they explain what BAMF Health is, break down the meaning of Theranostics, and discuss how precision medicine is transforming the way diseases like cancer are diagnosed and treated. They also share what listeners can expect from future episodes, including conversations with clinicians, researchers, athletes, innovators, and healthcare leaders exploring how we can all optimize our health.Whether you're interested in advanced cancer therapies, medical imaging, clinical trials, or the future of personalized healthcare, this podcast will explore the ideas, technologies, and people shaping the next generation of medicine.00:00 Introduction to the BAMF Health Podcast00:26 What is BAMF Health?01:05 What is Theranostics?01:49 Personalized Precision Medicine02:34 The Future of Healthcare & Patient Empowerment03:18 What to Expect From the Podcast04:04 Topics We'll Cover04:59 Episode Wrap-Up & Episode 1 PreviewConnect with the hosts on LinkedInBrandon: https://www.linkedin.com/in/brandon-mancini-md-mba-facro-44646758/ Christine: https://www.linkedin.com/in/christinevt/Connect with BAMF HealthWebsite: https://www.bamfhealth.com/Our Podcast: https://www.bamfhealth.com/podcast/Connect with the hosts on LinkedInDr. Brandon ManciniChristine VanTimmerenConnect with BAMF HealthOur WebsiteOur Podcast

Connect with the hosts on LinkedInDr. Brandon ManciniChristine VanTimmerenConnect with BAMF HealthOur WebsiteOur Podcast